A phenotypic and molecular investigation of biofilm formation in clinical samples of Pseudomonas aeruginosa

Document Type : Original article

Authors

Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

Abstract

Pseudomonas aeruginosa is identified as a versatile opportunistic microorganism with metabolic diversity contributing to a wide range of health burdens, especially in immunocompromised patients. This bacterium is the cause of 10 to 20% of nosocomial infections. In this study, we evaluated the phenotypic characterizations of biofilm formation in P. aeruginosa clinical isolates using micro-titer plate assay. Indeed, we estimated the prevalence of QS (rhlI, rhlR, rhlAB, lasB, lasI, lasR, aprA) and virulence genes (pslA and cupA) by PCR. The results showed that among 69% of the isolates forming biofilm, 9% were strong biofilm producers, whereas 13% and 47% of isolates produced moderate and low amounts of biofilm, respectively. All isolates possessed cupA and seven QS genes (rhlI, rhlR, rhlAB, lasB,  lasI, lasR, aprA), while 92% of the isolates possessed the pslA gene. Identification of these genes and their association with biofilm formation can be advantageous in adopting therapeutic methods.

Keywords

References

  1. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 2007;67:351-368.
  2. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 2007;19:83-88.
  3. Bhat S, Fujitani S, Potoski BA, Capitano B, Linden PK, Shutt K, Paterson DL. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical β-lactam antibiotic therapy be improved?. Int J Antimicrob Agents 2007;30:458-462.
  4. Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel’s specimens. J Res Med Sci 2012;17:332-337.
  5. Soukarieh F, Williams P, Stocks MJ, Cámara M. Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives. J Med Chem 2018;61:10385-10402.
  6. Gonzalez MR, Ducret V, Leoni S, Perron K. Pseudomonas aeruginosa zinc homeostasis: Key issues for an opportunistic pathogen. Biochim Biophys Acta Gene Regul Mech 2019;1862 :722-733.
  7. Azam MW, Khan AU. Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discov Today 2019;24:350-359.
  8. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:711-745.
  9. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007;5:48-56.
  10. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O’Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003;426:306-310.
  11. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28:546-556.
  12. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000;407:762-764.
  13. Sutherland IW. The biofilm matrix – an immobilized but dynamic microbial environment. Trends Microbiol 2001;9:222-227.
  14. Ma L, Jackson KD, Landry RM, Parsek MR, Wozniak DJ. Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol 2006;188:8213-8221.
  15. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol 2007;10:644-648.
  16. Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A. The chaperone/usher pathways of Pseudomonas aeruginosa: Identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci U S A 2001;98:6911-6916.
  17. Teresa R, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect Immun 2000;68:4839-4849.
  18. Fuqua WC,  Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulatorst. J Bacteriol 1994;176:269-275.
  19. Zhu H, Bandara R, Conibear TCR, Thuruthyil SJ, Rice SA, Kjelleberg S, Givskov M, Willcox MDP. Pseudomonas aeruginosa with LasI quorum-sensing deficiency during corneal infection. Investig Ophthalmol Vis Sci 2004;45:1897-1903.
  20. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.
  21. Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000;40:175-179.
  22. Shafiei M, Ali AA, Shahcheraghi F, Saboora A, Noghabi KA. Eradication of Pseudomonas aeruginosa biofilms using the combination of n-butanolic Cyclamen coum extract and ciprofloxacin. Jundishapur J Microbiol 2014;7:e14358.
  23. Emami S, Nikokar I, Ghasemi Y, Ebrahimpour M, Ebrahim-Saraie HS, Araghian A, Faezi S, Farahbakhsh M, Rajabi A. Antibiotic resistance pattern and distribution of pslA gene among biofilm producing Pseudomonas aeruginosa isolated from waste water of a burn center. Jundishapur J Microbiol 2015;8:e23669.
  24. Perez LRR, Costa MCN, Freitas ALP, Barth AL. Evaluation of biofilm production by Pseudomonas aeruginosa isolates recovered fromcystic fibrosis and non-cystic fibrosis patients. Braz J Microbiol 2011;42:476-479.
  25. Ghadaksaz A, Imani Fooladi AA, Hosseini HM, Amin M. The prevalence of some Pseudomonas virulence genes related to biofilm formation and alginate production among clinical isolates. J Appl Biomed 2015;13:61-68.
  26. Rodrigues RL, Lima JL da C, de Sena KX da FR, Maciel MAV. Phenotypic and genotypic analysis of biofilm production by Pseudomonas aeruginosa isolates from infection and colonization samples. Rev Soc Bras Med Trop 2020;53:e20200399.
  27. Samira H, Fereshteh E. Biofilm formation and β-lactamase production in burn isolates of Pseudomonas aeruginosa. Jundishapur J Microbiol 2015;8.e15514.
  28. Banar M, Emaneini M, Satarzadeh M, Abdellahi N, Beigverdi R, Van Leeuwen WB, Jabalameli F. Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections. PLoS One 2016; 11:e0164622.
  29. Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes 2020;13:4-9.
  30. Da Costa Lima JL, Alves LR, Da Paz JNP, Rabelo MA, Maciel MAV, De Morais MMC. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-Associated pneumonia. Rev Bras Ter Intensiva 2017;29:310-316.
  31. Lima JL da C, Alves LR, Jacomé PRL de A, Bezerra Neto JP, Maciel MAV, Morais MMC de. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non biofilm-producing. Braz J Infect Dis 2018;22:129-136.
  32. Fazli M, Almblad H, Rybtke ML, Givskov M, Eberl L, Tolker-Nielsen T. Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ Microbiol 2014; 16:1961-1981.
  33. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: Effects of growth phase and environment. J Bacteriol 2003;185:2080-2095.
  34. Perez LRR, Machado ABMP, Barth AL. The presence of quorum-sensing genes in pseudomonas isolates infecting cystic fibrosis and non-cystic fibrosis patients. Curr Microbiol 2013;66:418-420.
  35. Kadhim D, Ali MR. Prevalence study of quorum sensing groups among clinical isolates of Pseudomonas aeruginosa. Int J Curr Microbiol App Sci 2014;3:204-215.
  36. Boşgelmez-Tinaz G, Ulusoy S. Characterization of N-butanoyl-l-homoserine lactone (C4-HSL) deficient clinical isolates of Pseudomonasaeruginosa. Microb Pathog 2008;44:13-19.
  37. Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagci A. Quorum sensing and virulence of pseudomonas aeruginosa during urinary tract infections. J Infect Dev Ctries 2012;6:501-507.
  38. 38. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonasaeruginosa biofilm matrix. PLoS Pathog 2009;5:e1000354. 

Files

Share

How to cite

Statistics